NCT02213497View on ClinicalTrials.gov

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Esophageal Cancer
Interventions
RADIATION

18F-FDG (Fluorodeoxyglucose) PET

DRUG

Carboplatin

DRUG

Paclitaxel

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER